After the Executive branch the SEC is probably the most useless and corrupt of all government agencies. Even if they did find a company in violation they would fine them a fraction of what is just and pocket the money, not return it in any way, shape or form to shareholders. ZTE's and Google's crimes can only be delt with by the Judges on these cases and the fact that there hasn't been an award or even a substantial fine makes one wonder if they're also on the take. The only thing certain in any of these proceedings is that retail will get shafted. Again.
it better not last. over a 30% discount to the one month high. Too much. Let's see it come down below that for us lessor mortals to participate.
I always worry about insider transactions that are illegal. like i said, no problem with an offering but lots of problems with the sell off prior.
they always need cash (bonuses and the like) and the current price and the impending financial crash probably set the time. I have no problem with an offering. I do with the people who got insider info a month ago and sold off. Normally I hate class action but if the SEC doesn't step in then i'm all for one.
low volume jumps are generally enticements. Still time to be vigilant. still wise to buy on dips not jumps.
secondaries generally sell off before the announcement and after the run up. The volume hasn't been crazy. perhaps a short in trouble. I don't know but it is strange IMO
many things can happen in these patients in the blink of an eye but I suspect any insider shenanigans would have to do more with management/fiscal rather than clinical
For this stock to plummet like it has gives rise to insider mischief. While the SEC is worthless if news that woild justify it pops up soon file a complaint. Not much else one can do.
the odds for 3 for 3 conversions is where a PR should go. 4%- 5% can be argued, it happens. 3 consecutive odds beating effects in these injuries should be shocking statistically. Any statisticians out there? This now is remarkable. The bridge to neuro recovery has been established. Now refinement and method (stem cell) advancement should pave the way to the Nobel Prize.
like what? what's happening here is universal. retail gets screwed. SEC does nothing. ever notice when someone gets fined it's always for a fraction of what they stole and shareholders never get any of the fine money. management of any stock is part of the problem. Only way to stop it is for everyone to pull all their money out and watch them squirm as they circle the toilet. Any chance? Not a smidgen of one. if you need to play for any reason then be prepared to pay.
i prefer that scenario but I'd venture it's 80/10 chance that mine is more likely and a 10 % that nothing is happening. Volume pitiful
I agree with your thoughts and logic. There is room for both and the need and prevalence of either will be decided going forward. If success early on is a catalyst for stock strength and future success then using what appears to be a very successful cell farm early on bodes well. And others are out there with scaffold type technology that could try it successfully and trump NVIV's first in class are an investor concern. Not sure about patent application that might come into play here. In a new frontier i believe it is good to stake your claim early and broadly. I appreciate your thoughts and insights on the topic.